| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An endothelium-derived angiogenesis inhibitor vasohibin and its significance in tumor angiogenesis
|
Sato, Yasufumi
|
|
2006
|
58 |
7 |
p. 69-72
|
artikel
|
| 2 |
A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan
|
Ichinose, Yukito
|
|
2006
|
58 |
7 |
p. 43-48
|
artikel
|
| 3 |
Clinical development of EGFR-tyrosine kinase inhibitors in Japan
|
Nakagawa, Kazuhiko
|
|
2006
|
58 |
7 |
p. 33-37
|
artikel
|
| 4 |
Defining clinically relevant molecular subsets of lung cancer
|
Pao, William
|
|
2006
|
58 |
7 |
p. 11-15
|
artikel
|
| 5 |
Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor
|
Kimura, Shinya
|
|
2006
|
58 |
7 |
p. 55-61
|
artikel
|
| 6 |
EGFR mutation in various tissues
|
Nishio, Kazuto
|
|
2006
|
58 |
7 |
p. 39-41
|
artikel
|
| 7 |
Impact of EGFR mutations on treatment of non-small cell lung cancer
|
Johnson, Bruce E.
|
|
2006
|
58 |
7 |
p. 5-9
|
artikel
|
| 8 |
Improving upon the promise of targeted therapy of human malignancy: chronic myeloid leukemia as a paradigm
|
Shah, Neil P.
|
|
2006
|
58 |
7 |
p. 49-53
|
artikel
|
| 9 |
Molecular classification of tumors with special reference to EGFR mutation in lung cancer
|
Yatabe, Yasushi
|
|
2006
|
58 |
7 |
p. 17-23
|
artikel
|
| 10 |
Preface
|
Ariyoshi, Yutaka
|
|
2006
|
58 |
7 |
p. 1-3
|
artikel
|
| 11 |
RNAi, microRNAs, and human disease
|
Hammond, Scott M.
|
|
2006
|
58 |
7 |
p. 63-68
|
artikel
|
| 12 |
The impact and role of EGFR gene mutation on non-small cell lung cancer
|
Toyooka, Shinichi
|
|
2006
|
58 |
7 |
p. 25-31
|
artikel
|
Tijdschrift beschrijving